bullish

Roche Holding AG

Roche Holding (ROG SW): Despite Patent Cliff Growth Momentum to Continue Backed by New Launches

Continuous portfolio rejuvenation has helped Roche to more than offset the sales erosion caused by biosimilar competition. This year, the company has launched one new drug, two more to follow.

Equity Bottom-Up
294 Views, 20 Apr 2022 15:48
SUMMARY
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Data & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now

Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Health CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Roche Holding (ROG SW): Despite Patent Cliff Growth Momentum to Continue Backed by New Launches
    20 Apr 2022
  • Liquid Universe of European Ordinary and Preferred Shares: December Report
    18 Dec 2021
  • KKR Potential Offer for The (W)Hole of Telecom Italia
    23 Nov 2021
  • Liquid Universe of European Ordinary and Preferred Shares: November Report
    17 Nov 2021
x